Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy?
2021
Patients and physicians may be concerned about starting a biologic treatment during the COVID-19 pandemic. Whether biologics enhance the risk of being infected with SARS-CoV-2 or if the disease course is worsened, remain to be ascertained. So far, no negative signal emerged for an increased risk of severe COVID-19 associated with biologics when compared with the general population.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
1
Citations
NaN
KQI